Lundbeck
HLUN-B.CO
#2641
Rank
โ‚น576.02 B
Marketcap
โ‚น606.93
Share price
0.65%
Change (1 day)
26.13%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น54.83. In 2024 the company made an earnings per share (EPS) of โ‚น39.59 an increase over its 2023 EPS that were of โ‚น30.62.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น52.7933.33%
2024โ‚น39.5929.29%
2023โ‚น30.6223.09%
2022โ‚น24.8837.26%
2021โ‚น18.12-84.61%
2020โ‚น117.77-24.61%
2019โ‚น156.21-42.06%
2018โ‚น269.6140.7%
2017โ‚น191.63146.26%
2016โ‚น77.82-120.48%
2015-โ‚น379.883231.32%
2014-โ‚น11.40-115.78%
2013โ‚น72.25-23.36%
2012โ‚น94.28-48.01%
2011โ‚น181.35-9.68%
2010โ‚น200.8013.72%
2009โ‚น176.5724.32%
2008โ‚น142.03-6.05%
2007โ‚น151.1781.77%
2006โ‚น83.17-16.76%
2005โ‚น99.92-17.58%
2004โ‚น121.23